Abstract
BackgroundT cell responses are at the core of checkpoint inhibitor success in treating cancer; however, generating targeted antigen presentation to stimulate T cell responses remains challenging. Here, we take advantage...
Published Version (Free)
Talk to us
Join us for a 30 min session where you can share your feedback and ask us any queries you have